Ovidio
Fernández Calvo
Pfizer (United States)
Nueva York, Estados UnidosPublicacións en colaboración con investigadores/as de Pfizer (United States) (3)
2023
-
Long-term Clinical Outcomes of a Spanish Cohort of Metastatic Renal Cell Carcinoma Patients with a Complete Response to Sunitinib
Clinical Genitourinary Cancer, Vol. 21, Núm. 3, pp. e166-e174
2022
-
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study
Clinical Genitourinary Cancer, Vol. 20, Núm. 1, pp. 25-34
2011
-
Expression of notch1 to -4 and their ligands in renal cell carcinoma: A tissue microarray study
Cancer Genomics and Proteomics, Vol. 8, Núm. 2, pp. 93-101